Sutro Biopharma Inc
STRO9.980USD
+1.050+11.76%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
84.93MMarket Cap
LossP/E TTM
Sutro Biopharma Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
62.04M
-59.64%
EPS(YoY)
-29.61
-1567.90%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its total revenue reached 62.04M, with a year-on-year change of -59.64%.
What is the Earnings Per Share (EPS) of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -29.606, with a year-on-year change of -1567.90%.
What is the net income of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its net income was -227.46M, with a year-on-year change of -112.99%.
What is the net margin of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its net profit margin was -366.62%, with a year-on-year change of -427.76%.
What is the gross margin of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of -100.00%.
What is the Return on Equity (ROE) of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its Return on Equity (ROE) was -234.19%, with a year-on-year change of -302.08%.
What is the Return on Assets (ROA) of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its Return on Assets (ROA) was -53.02%, with a year-on-year change of -117.89%.
What is the operating profit of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its operating profit was -238.45M, with a year-on-year change of -167.09%.
What are the current assets of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its current assets were 343.31M, with a year-on-year change of -18.56%.
What are the total assets of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its total assets of Sutro Biopharma Inc were 387.21M, with a year-on-year change of -17.74%.
What are the total liabilities of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its total liabilities of Sutro Biopharma Inc were 342.61M, with a year-on-year change of 6.70%.
What is the total equity of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its total equity of Sutro Biopharma Inc was 44.60M, with a year-on-year change of -70.20%.
What is the net operating income of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its net operating income of Sutro Biopharma Inc was -227.46M, with a year-on-year change of -112.99%.
What is the net investment of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its net investment of Sutro Biopharma Inc was 218.51M, with a year-on-year change of 5668.50%.
What is the net financing of Sutro Biopharma Inc?
According to Sutro Biopharma Inc's FY2024 earnings report, its net financing of Sutro Biopharma Inc was 94.05M, with a year-on-year change of -31.62%.
